Saturday 17 October 2026
Export BTMD’s income statement to Excel — free account
biote Corp.
BTMD Healthcare Medical Care Facilities
biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024. In the quarter to June 2026, revenue fell 9.48%, EPS fell 330.0%, free cash flow fell 174.2% and total debt rose 16.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.09
0.02
−1.80%
Follow BTMD
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | 9.56 | 2.00 | 2.75 | 3.65 | 2.32 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | 10.10 | 10.53 | 8.22 | 8.44 | 6.36 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | 4 | 186 | 194 | 217 | 223 | ||||
| Revenue/emp, $m | — | — | — | — | — | 34.85 | 0.89 | 0.96 | 0.91 | 0.86 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 139 | 165 | 185 | 197 | 192 | ||||
| Gross margin, % | — | — | — | — | — | 64.98 | 66.92 | 68.78 | 70.52 | 71.46 | |||||
| EBT | — | — | — | — | 0 | 33 | 2 | 0 | 1 | 38 | |||||
| EBT margin, % | — | — | — | — | 0.00 | 23.61 | 1.04 | (0.07) | 0.52 | 19.55 | |||||
| Net income | — | 0 | — | — | 0 | 33 | 1 | (3) | 0 | 32 | |||||
| Depreciation | — | — | — | — | — | 2 | 3 | 4 | 4 | 5 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | 0.00 | 18.40 | 20.47 | 7.21 | 5.75 | 6.14 | ||||
| Earnings | — | — | — | — | — | 0.64 | (0.12) | 0.13 | 0.09 | 0.86 | |||||
| Cash flow | — | — | — | — | 0.00 | 4.45 | (1.14) | 1.05 | 1.32 | 1.13 | |||||
| Capex | — | — | — | — | 0.00 | (0.50) | (0.23) | (0.11) | (0.20) | (0.22) | |||||
| Free cash flow | — | — | — | — | 0.00 | 3.95 | (1.36) | 0.94 | 1.12 | 0.91 | |||||
| Book value | — | — | — | — | 0.00 | 0.54 | (7.23) | (1.42) | (2.98) | (1.61) | |||||
| Shares, m | — | — | — | — | 8 | 8 | 8 | 26 | 34 | 31 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | 0.00 | 0.26 | 0.00 | 29.43 | 3.02 | ||||
| P/S | — | — | — | — | — | 0.00 | 0.18 | 0.66 | 1.07 | 0.42 | |||||
| P/B | — | — | — | — | — | 18.68 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | 0.00 | 0.41 | 0.78 | 1.42 | 0.85 | |||||
| EV/FCF | — | — | — | — | — | 2.92 | (6.20) | 6.02 | 7.31 | 5.80 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | 0 | 34 | (9) | 27 | 45 | 35 | ||||
| Capex | — | — | — | — | — | (4) | (2) | (3) | (7) | (7) | |||||
| Free cash flow | — | — | — | — | 0 | 30 | (11) | 24 | 38 | 28 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | 0 | 30 | 82 | 100 | 17 | 10 | ||||
| Total debt | — | — | — | — | — | 37 | 118 | 113 | 107 | 107 | |||||
| Net debt | — | — | — | — | 0 | 10 | 39 | 24 | 68 | 83 | |||||
| Shareholders’ equity | — | — | — | — | 0 | 4 | (58) | (37) | (102) | (50) | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | 0.00 | 119.75 | (1.17) | 2.48 | 2.27 | 23.52 | ||||
| ROIC | — | — | — | — | 0.00 | 150.82 | 0.00 | 0.00 | 0.00 | 68.34 | |||||
| ROE | — | — | — | — | 0.00 | 1,572.00 | 3.58 | (6.99) | (4.55) | (35.45) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
biote Corp. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| AIRS AirSculpt Technologies, Inc. | $102.0M | — (loss-making) | — (loss-making) | −2.53% (below 0%: shrinking) | n/m | −131.07% (below 0%: shrinking) | 61.38% | (0.07%) | Compare |
| JYNT The Joint Corp. | $97.7M | 26.0× | 16.9× | +14.41% (above 0%: growing) | +400.00% (above 0%: growing) | +432.31% (above 0%: growing) | 83.68% | (2.43%) | Compare |
| PARK Park Dental Partners, Inc. | $91.3M | — (loss-making) | — | +12.15% (above 0%: growing) | −65.84% (below 0%: shrinking) | −34.78% (below 0%: shrinking) | 14.37% | 1.90% | Compare |
| BTMD biote Corp. | $39.9M | 6.8× | 11.0× | −9.48% (below 0%: shrinking) | n/m | −174.16% (below 0%: shrinking) | 65.38% | (7.93%) | |
| PIII P3 Health Partners Inc. | $30.1M | — (loss-making) | — | +8.60% (above 0%: growing) | n/m | −272.24% (below 0%: shrinking) | 22.26% | 10.67% | Compare |
| CCEL Cryo-Cell International Inc. | $29.4M | — (loss-making) | 43.8× | −0.02% (below 0%: shrinking) | +77.78% (above 0%: growing) | −58.37% (below 0%: shrinking) | 79.38% | 28.04% | Compare |
| DCGO DocGo Inc. | $27.9M | — (loss-making) | — (loss-making) | −8.70% (below 0%: shrinking) | n/m | −132.28% (below 0%: shrinking) | 30.52% | (24.41%) | Compare |
| PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR | $15.9M | — (loss-making) | 8.3× | +25,427.42% (above 0%: growing) | n/m | −206.36% (below 0%: shrinking) | 42.70% | (1.24%) | Compare |
| CCM Concord Medical Services Holdings Limited | $10.5M | — (loss-making) | — (loss-making) | +37.65% (above 0%: growing) | n/m | −281.45% (below 0%: shrinking) | (13.15%) | 0.00% | Compare |
| Median of peers | $29.7M | — | 16.9× | +10.38% | +77.78% | −131.67% | 36.61% | (0.03%) |
biote Corp. (BTMD) key facts
- Concern: biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024.
- biote Corp. (BTMD) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, BTMD traded at $1.09, a market capitalization of $39.9 million.
- Return on equity was −35.5% and debt-to-equity -2.09.
- Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 2.65 (grey zone) for fiscal 2025.
biote Corp. (BTMD) Latest News
No news at this impact. Lower the threshold for more.